Cargando…
CpG-coated Prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma
High-risk neuroblastoma, which is associated with regional and systemic metastasis, is a leading cause of cancer-related mortality in children. Responding to this need for novel therapies for high-risk patients, we have developed a “nanoimmunotherapy,” which combines photothermal therapy (PTT) using...
Autores principales: | Cano-Mejia, Juliana, Shukla, Anshi, Ledezma, Debbie K., Palmer, Erica, Villagra, Alejandro, Fernandes, Rohan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348061/ https://www.ncbi.nlm.nih.gov/pubmed/32652470 http://dx.doi.org/10.1016/j.tranon.2020.100823 |
Ejemplares similares
-
Anti-Fn14-Conjugated Prussian Blue Nanoparticles as a Targeted Photothermal Therapy Agent for Glioblastoma
por: Bonan, Nicole F., et al.
Publicado: (2022) -
The Thermal Dose of Photothermal Therapy Generates Differential Immunogenicity in Human Neuroblastoma Cells
por: Sekhri, Palak, et al.
Publicado: (2022) -
Prussian Blue Nanoparticles as a Versatile Photothermal Tool
por: Dacarro, Giacomo, et al.
Publicado: (2018) -
Hollow Prussian Blue Nanospheres for Photothermal/Chemo-Synergistic Therapy
por: Lu, Long, et al.
Publicado: (2020) -
Indocyanine Green-Nexturastat A-PLGA Nanoparticles Combine Photothermal and Epigenetic Therapy for Melanoma
por: Ledezma, Debbie K., et al.
Publicado: (2020)